The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.EBI
National Tsing Hua University
KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor.EBI
National Tsing Hua University
Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors.EBI
National Tsing Hua University
Design and synthesis of alpha-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis.EBI
National Tsing Hua University
Suramin derivatives play an important role in blocking the interaction between FGF1 and FGFRD2 to inhibit cell proliferation.EBI
National Tsing Hua University
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonistsBDB
Boehringer Ingelheim International
Selective glycosidase inhibitors and uses thereofBDB
Merck Sharp & Dohme